title: Modeling NSCLC progression: recent advances and opportunities available.
abstract: Non-small cell lung cancer (NSCLC) is one of the leading causes of death around the world with an estimated 5-year relative survival rate of 16% at diagnosis. Development of drugs treating NSCLC is not easy, and the success rate for an anticancer treatment to pass through the whole clinical development process is as low as 5%. Modeling and simulation lend themselves as tools which can potentially streamline drug development. A critical component of the models developed is a description of how the disease progresses over time and how a treatment would affect its trajectory. Our aim was to review the literature to present the models and growth functions which have been used for describing NSCLC dynamics, and how anticancer treatments can affect such dynamics, both in animals and in humans. Only a limited set of models were identified for such a purpose. Most of the models which have been used were descriptive of tumor growth, yet there were attempts to account for the underlying processes, especially in animals where it is more feasible to collect data needed for developing such models. Moreover, we discuss how modeling and simulation can aid in decision making across the different stages of drug development. Based on some encouraging results from trials of other cancer types where modeling tumor dynamics has played an important role, we propose further exploration of NSCLC using model-based techniques and further use of these techniques in designing and evaluating NSCLC trials.
authors: Department of Pharmacology, University Hospital of Cologne, Gleueler Strasse 24, 50931 Cologne, Germany. ahmed.suleiman@uk-koeln.de
authors: Ahmed Abbas
authors: AA
authors: Suleiman
authors: Lucia
authors: L
authors: Nogova
authors: Uwe
authors: U
authors: Fuhr
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D049109:Cell Proliferation / Q000187:drug effects; D002986:Clinical Trials as Topic / Q000379:methods; D003198:Computer Simulation; D003661:Decision Support Techniques; D018450:Disease Progression; D055808:Drug Discovery / Q000379:methods*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D008954:Models, Biological; D015233:Models, Statistical; D012107:Research Design; D013997:Time Factors; D057170:Translational Research, Biomedical; D016896:Treatment Outcome; D047368:Tumor Burden / Q000187:drug effects
chemical_list: D000970:Antineoplastic Agents
references: Clin Pharmacol Ther. 2012 Nov;92(5):548-50
references: 23085878
references: J Clin Oncol. 1988 Sep;6(9):1365-7
references: 3047331
references: Annu Rev Pharmacol Toxicol. 2001;41:625-59
references: 11264471
references: J Clin Oncol. 2006 Jun 1;24(16):2505-12
references: 16636341
references: Nat Med. 2006 Aug;12(8):875-8
references: 16892025
references: J Clin Oncol. 2012 Aug 10;30(23):2829-36
references: 22753922
references: Br J Clin Pharmacol. 2002 Aug;54(2):203-11
references: 12207643
references: J Clin Oncol. 1997 May;15(5):1858-69
references: 9164196
references: Nat Rev Cancer. 2006 May;6(5):409-14
references: 16633367
references: J Pharm Sci. 1971 Jun;60(6):892-5
references: 5166939
references: Clin Cancer Res. 2003 Sep 15;9(11):4227-39
references: 14519650
references: AAPS J. 2005 Oct 07;7(3):E544-59
references: 16353932
references: J Clin Oncol. 2008 Aug 1;26(22):3665-7
references: 18669449
references: J Clin Oncol. 2009 Jan 20;27(3):439-45
references: 19064982
references: Cancer Res. 1988 Dec 15;48(24 Pt 1):7067-71
references: 3191483
references: Eur J Cancer. 2008 Jan;44(1):142-50
references: 18039567
references: JAMA. 2003 Oct 22;290(16):2149-58
references: 14570950
references: J Natl Cancer Inst. 2009 Nov 18;101(22):1592-3; author reply 1593-4
references: 19864637
references: Clin Pharmacol Ther. 2012 Nov;92(5):631-4
references: 22910440
references: J Clin Pharmacol. 2011 Jan;51(1):6-8
references: 20628172
references: Drug Discov Today Technol. 2013 Sep;10(3):e365-72
references: 24050133
references: Ann Oncol. 2011 Sep;22(9):2057-2067
references: 21321086
references: Expert Opin Drug Metab Toxicol. 2012 Sep;8(9):1057-69
references: 22632710
references: Nat Rev Drug Discov. 2004 Aug;3(8):711-5
references: 15286737
references: CA Cancer J Clin. 2011 Nov-Dec;61(6):365-81
references: 22034206
references: J Pharmacokinet Pharmacodyn. 2005 Apr;32(2):185-97
references: 16283534
references: Cancer. 1975 Jan;35(1):15-24
references: 1109768
references: CA Cancer J Clin. 2012 Jan-Feb;62(1):10-29
references: 22237781
references: Trends Pharmacol Sci. 2008 Apr;29(4):186-91
references: 18353445
references: Cell. 2009 Dec 24;139(7):1315-26
references: 20064377
references: Clin Pharmacol Ther. 1997 Mar;61(3):275-91
references: 9084453
references: J Clin Oncol. 2003 Jun 15;21(12):2237-46
references: 12748244
references: Br J Clin Pharmacol. 2003 Feb;55(2):147-57
references: 12580986
references: Br J Cancer. 2001 May 18;84(10):1424-31
references: 11355958
references: J Clin Oncol. 2009 Sep 1;27(25):4103-8
references: 19636014
references: Annu Rev Pharmacol Toxicol. 2007;47:357-400
references: 17067280
references: Cancer Res. 2006 Apr 1;66(7):3355-8, discussion 3358-9
references: 16585152
references: Cancer Res. 2004 Feb 1;64(3):1094-101
references: 14871843
references: Nat Rev Drug Discov. 2006 Sep;5(9):741-54
references: 16915232
references: Cancer Res. 1993 Sep 1;53(17):3964-7
references: 8358724
references: J Nucl Med. 2009 May;50 Suppl 1:122S-50S
references: 19403881
references: J Pharmacokinet Pharmacodyn. 2004 Dec;31(6):419-40
references: 16222783
references: Int J Cancer. 2010 Dec 15;127(12):2893-917
references: 21351269
references: Br J Obstet Gynaecol. 1994 Apr;101(4):319-24
references: 8199078
references: Cancer Clin Trials. 1981 Winter;4(4):451-7
references: 7318127
references: PLoS Med. 2005 Jan;2(1):e17
references: 15696205
references: Eur J Cancer. 2007 Aug;43(12):1862-8
references: 17604156
references: J Natl Cancer Inst. 2007 Oct 3;99(19):1455-61
references: 17895472
references: Nat Rev Clin Oncol. 2009 May;6(5):259-65
references: 19390552
references: J Clin Oncol. 2004 Mar 1;22(5):785-94
references: 14990633
references: Cancer Chemother Pharmacol. 1988;21(3):185-90
references: 3129204
references: J Control Release. 1999 Aug 27;61(1-2):93-106
references: 10469906
references: Nature. 1976 Dec 9;264(5586):542-5
references: 1004590
references: Expert Opin Drug Discov. 2007 Feb;2(2):185-209
references: 23496077
references: Pharm Stat. 2009 Jul-Sep;8(3):176-85
references: 19626596
references: N Engl J Med. 2003 Jul 31;349(5):427-34
references: 12890841
references: Annu Rev Pharmacol Toxicol. 2009;49:291-301
references: 18851702
references: Clin Pharmacol Ther. 2012 Jul;92(1):125-31
references: 22617225
references: Nat Rev Clin Oncol. 2011 Jun;8(6):369-77
references: 21522121
references: Ther Drug Monit. 2011 Feb;33(1):99-107
references: 21192315
references: J Clin Pharmacol. 2008 May;48(5):632-49
references: 18440922
references: J Natl Cancer Inst. 2000 Feb 2;92(3):205-16
references: 10655437
references: N Engl J Med. 2008 Sep 25;359(13):1367-80
references: 18815398
references: Clin Pharmacol Ther. 2009 Aug;86(2):167-74
references: 19440187
references: Pharm Res. 2000 Nov;17(11):1335-44
references: 11205725
references: J Clin Oncol. 2011 May 1;29(13):1701-8
references: 21422426
references: J Clin Oncol. 2004 Mar 1;22(5):777-84
references: 14990632
references: N Engl J Med. 2004 May 20;350(21):2129-39
references: 15118073
references: BMC Med Inform Decis Mak. 2008 Jan 28;8:6
references: 18226244
references: Breast Dis. 2010;31(1):7-18
references: 20519801
references: Clin Cancer Res. 2008 Jul 1;14(13):4213-8
references: 18594002
references: Annu Rev Biochem. 1998;67:753-91
references: 9759503
references: J Theor Biol. 2010 Jun 7;264(3):990-1002
references: 20138060
references: J Clin Oncol. 2004 Nov 15;22(22):4442-5
references: 15483011
references: Clin Pharmacol Ther. 2009 Aug;86(2):136-8
references: 19621009
references: Proc Natl Acad Sci U S A. 1992 Dec 1;89(23):11466-70
references: 1454835
references: N Engl J Med. 2010 Oct 28;363(18):1693-703
references: 20979469